Skip to content

OPN Balloon for SAFE Recanalization of Calcified Coronary Lesions

OPN Balloon for SAFE Recanalization of Calcified Coronary Lesions (OPEN-SAFE Registry)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07646444
Acronym
OPEN-SAFE
Enrollment
300
Registered
2026-06-12
Start date
2026-08-01
Completion date
2027-06-01
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcified Coronary Lesions, Coronary Arterial Disease (CAD), In Stent Restenosis

Brief summary

The goal of the OPEN-SAFE registry is to describe the contemporary use and outcomes of SIS-OPN in North America.

Interventions

DEVICEnon compliant balloon

This is a registry tracking the use and outcomes of the OPN NC balloon, a non-compliant balloon

Sponsors

Minneapolis Heart Institute Foundation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Subjects who underwent a clinically indicated PCI procedure that involved at least one OPN balloon * Date range for data collection will be from February 1, 2023 to December 31, 2028

Exclusion criteria

* Subjects who have opted out of being included in research related data collection

Design outcomes

Primary

MeasureTime frameDescription
In-Hospital OutcomesperiproceduralDescriptive summaries of incidence of in-hospital outcomes and MACE
Treatment Utilizationintra-proceduraldescriptive summaries of various treatments utilized before and after use of the OPN balloon
Predictors of Success and Failure for the OPN Balloonintra-proceduralAssess predictors for failure of the OPN balloon

Countries

United States

Contacts

CONTACTBavana V Rangan, BDS, MPH
Bavana.Rangan@allina.com612-863-4768

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026